InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-34.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Paggiarino Dario A., Directeur Médical. Director active across 1 company, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 15 reports have been logged. Activity tracked since 14 June 2021. The latest transaction was filed on 30 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
5,834 shares0Common StockSEC:0001562180-24-003193:0
4,967 shares0Common StockSEC:0001562180-24-001293:0
15,609 shares@ US$12.9031.3% of flowCommon StockSEC:0001562180-24-000808:0
300 shares@ US$13.130.6% of flowCommon StockSEC:0001562180-24-000784:0
3,096 shares@ US$13.136.3% of flowCommon StockSEC:0001562180-24-000637:0
22,913 shares@ US$3.2611.5% of flowCommon StockSEC:0001562180-24-000414:0
15,285 shares0Common StockSEC:0001562180-24-000403:0
1,458 shares@ US$10.132.3% of flowCommon StockSEC:0001562180-23-008415:0
30,625 shares@ US$10.1348.0% of flowCommon StockSEC:0001562180-23-008171:0
4,967 shares0Common StockSEC:0001562180-23-001337:0
4,105 shares0Common StockSEC:0001562180-22-002136:0
4,966 shares0Common StockSEC:0001562180-22-001413:0
4,966 shares0Common StockSEC:0001562180-22-001413
1,420 shares0Common StockSEC:0001562180-21-004274
1,420 shares0Common StockSEC:0001562180-21-004274:0
15 of 15 declarations
About Paggiarino Dario A.
Paggiarino Dario A. is the Chief Medical Officer of EyePoint Pharmaceuticals, Inc. He is responsible for leading the company's medical and clinical initiatives. His role is essential for the development of new treatments and ensuring compliance with medical regulations. Dario brings significant expertise in the medical field, contributing to the mission of EyePoint Pharmaceuticals.
